Live Breaking News & Updates on Global discovery chemistry

Stay informed with the latest breaking news from Global discovery chemistry on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Global discovery chemistry and stay connected to the pulse of your community

OcuSciences Welcomes Michael Patane, PhD, to its Board of Directors

ANN ARBOR, Mich.--(BUSINESS WIRE)--Feb 20, 2024--

United-states , Michael-patane , Kurt-riegger , Mitobridge-inc , Medicinal-chemistry-at-millennium-pharmaceuticals , Ocusciences-inc , Kiora-pharmaceuticals , Eyegate-pharmaceuticals-inc , Chief-scientific-officer , Eyegate-pharmaceuticals , Global-discovery-chemistry , Novartis-institutes

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Harlan-weisman , Michael-patane , Corey-davis , Novartis , Merck-co , Scripps-research-institute , University-of-southern-california , Fordham-university , Millennium-pharmaceuticals , Company-quarterly-report-on-form

PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board

PhoreMost Ltd. announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB).

Babraham , Cambridgeshire , United-kingdom , London , City-of , Lily-ramsey , Peter-parker , Lorenz-mayr , Jason-imbriglio , Merck-global-discovery-chemistry-department , Phoremost-ltd , Babraham-institute

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

Norway , Australia , United-states , United-kingdom , Portugal , Austria , Canada , Germany , New-zealand , Netherlands , Denmark , Belgium

Monte Rosa Therapeutics Expands Senior Management Team

Published: Feb 08, 2021

Silvia Buonamici, Ph.D.,

BOSTON--(BUSINESS WIRE)-- Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing proteins, announced today the appointments of Owen Wallace, Ph.D., as Chief Scientific Officer and Silvia Buonamici, Ph.D., as Senior Vice President, Drug Discovery Biology, as the company continues to expand its executive leadership team. Drs. Wallace and Buonamici will oversee the research and development of the company’s pipeline of molecular glue degrader programs.
“As we continue to build out the Monte Rosa team and advance multiple new therapies toward clinical development, we are thrilled to welcome Owen and Silvia to the team,” said Monte Rosa CEO Markus Warmuth, M.D. “Owen brings more than two decades of experience leading drug discovery and development and will be a significant asset to the team as we bring our protein degrader therapies into clinical trials. Silvia’s previous leadership in oncology drug discovery both in industry and in academia will help to streamline research processes and fully utilize our in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and bring to life the next generation of molecular glue degraders.”

Italy , Boston , Massachusetts , United-states , Switzerland , Silvia-buonamici , Monte-rosa , Markus-warmuth , Owen-wallace , Eli-lilly , Bristol-myers-squibb , Yale-university